COST-EFFECTIVENESS OF A RENAL HEALTH PROGRAM IN PATIENTS WITH HYPERTENSIVE AND/OR DIABETES INDUCED CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Rosselli, D. [1 ]
DeAntonio, R. [2 ]
Calderon, C. [1 ]
Sanabria, M. [3 ]
机构：
[1] Independiente, Bogota, DC, Colombia
[2] Independent, Bogota, Colombia
[3] Baxter Colombia, Bogota, Cundinamarca, Colombia
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)74062-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of epoetin alfa in patients on chronic kidney dialysis
    Hollenbeak, Christopher
    Davies, Andrew
    McClellan, William M.
    de Lissovoy, Gregory
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A45 - A45
  • [32] The Community Diabetes Education (CoDE) Program Cost-Effectiveness and Health Outcomes
    Prezio, Elizabeth A.
    Pagan, Jose A.
    Shuval, Kerem
    Culica, Dan
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2014, 47 (06) : 771 - 779
  • [33] Cost-effectiveness of a telemonitoring program (telEPOC program) in frequently admitted chronic obstructive pulmonary disease patients
    Esteban, Cristobal
    Anton, Ane
    Moraza, Javier
    Iriberri, Milagros
    Larrauri, Mateo
    Mar, Javier
    Aramburu, Amaia
    Quintana, Jose M.
    JOURNAL OF TELEMEDICINE AND TELECARE, 2024, 30 (01) : 156 - 164
  • [34] Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes
    Suzuki, Yuta
    Hoshi, Keika
    Shiroiwa, Takeru
    Fukuda, Takashi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (09) : 728 - 736
  • [35] Cost-effectiveness analysis of lifestyle interventions for preventing kidney disease in patients with type 2 diabetes
    Yuta Suzuki
    Keika Hoshi
    Takeru Shiroiwa
    Takashi Fukuda
    Clinical and Experimental Nephrology, 2023, 27 : 728 - 736
  • [36] Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
    Erickson, Kevin F.
    Japa, Sohan
    Owens, Douglas K.
    Chertow, Glenn M.
    Garber, Alan M.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1250 - 1258
  • [37] Cost-effectiveness of chronic kidney disease mass screening test in Japan
    Kondo, Masahide
    Yamagata, Kunihiro
    Hoshi, Shu-Ling
    Saito, Chie
    Asahi, Koichi
    Moriyama, Toshiki
    Tsuruya, Kazuhiko
    Yoshida, Hideaki
    Iseki, Kunitoshi
    Watanabe, Tsuyoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (02) : 279 - 291
  • [38] Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease
    Tisdale, Rebecca L.
    Cusick, Marika M.
    Aluri, Kelly Zhang
    Handley, Thomas J.
    Joyner, Alice Kate Cummings
    Salomon, Joshua A.
    Chertow, Glenn M.
    Goldhaber-Fiebert, Jeremy D.
    Owens, Douglas K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (13) : 3380 - 3387
  • [39] COST-EFFECTIVENESS OF EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE (CKD) MANAGEMENT IN THE UK
    Ramos, M.
    Gerlier, L.
    Uster, A.
    Aguirre, A. R.
    Muttram, L.
    Frankel, A. H.
    Lamotte, M.
    VALUE IN HEALTH, 2023, 26 (12) : S131 - S132
  • [40] Cost-effectiveness of chronic kidney disease mass screening test in Japan
    Masahide Kondo
    Kunihiro Yamagata
    Shu-Ling Hoshi
    Chie Saito
    Koichi Asahi
    Toshiki Moriyama
    Kazuhiko Tsuruya
    Hideaki Yoshida
    Kunitoshi Iseki
    Tsuyoshi Watanabe
    Clinical and Experimental Nephrology, 2012, 16 : 279 - 291
12345